---
schema_version: "secwatch.filing_event.v1"
accession: "0000950170-22-003943"
form_type: "8-K"
ticker: "MEDP"
cik: "0001668397"
company_name: "Medpace Holdings, Inc."
filed_at: "2022-03-16T23:59:59+00:00"
generated_at: "2026-06-26T22:23:54.466746+00:00"
event_type: "other_material"
sentiment: "positive"
materiality_score: 0.6
calibrated_materiality_score: 0.6
confidence: "high"
source: SEC EDGAR
---

# Medpace increases credit facility to $250M and expands share buyback by $200M

## Summary
- Amendment No. 4 raises line of credit from $50M to $250M with PNC Bank, maturing March 31, 2023.
- Board approved $200M increase to stock repurchase program; 1,782,136 shares repurchased since Feb 11, 2022.
- Repurchases reduced outstanding shares by ~5%; 33,723,904 shares outstanding as of March 14, 2022.
- Interest options include Base Rate or Term SOFR +1.00%; anti-money laundering compliance updated.

## SEC filing metadata
- accession: 0000950170-22-003943
- form_type: 8-K
- ticker: MEDP
- cik: 0001668397
- company_name: Medpace Holdings, Inc.
- filed_at: 2022-03-16T23:59:59+00:00
- event_type: other_material
- sentiment: positive
- materiality_score: 0.6
- calibrated_materiality_score: 0.6
- confidence: high
- sec_items: 1.01, 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1668397/000095017022003943/0000950170-22-003943-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1668397/000095017022003943/medp-20220315.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0000950170-22-003943
- JSON: https://secwatch.observer/filing/0000950170-22-003943.json
- Plain text: https://secwatch.observer/filing/0000950170-22-003943.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.